Skip to main content

AAPM 39th Annual Meeting Enduring Content

The AAPM 39th Annual Meeting, held March 23-26, 2023, included over 50 educational sessions and events highlighting the most relevant and timely topics in pain medicine. The enduring content provides you access to a curated portion of those sessions. These recordings feature experts from around the country discussing the full spectrum of multidisciplinary care pain treatments.

If you have any questions please email info@painmed.org

*NOTE: Specific presentations within a session may not be available or may be audio only if the presenter has confidential patient information or otherwise declines to be recorded.

Technical Support
If you need further assistance with software requirements, please contact support@blueskyelearn.com

Faculty/Planner Disclosures & Policy
AAPM plans and implements educational activities in accordance with ACCME which calls on accredited providers to offer educational activities that address physicians’ real-world practice needs, whether their scope of practice is in clinical care, research, health care administration, or other areas of medicine. AAPM's educational programs are designed to change either physicians’ competence, by teaching them strategies for translating new knowledge into action, or physicians’ performance (what they actually do in practice), or patient outcomes. AAPM continually evaluates its programs’ effectiveness in achieving these goals.

All program faculty and planners are required to disclose all financial relationships they may have or have had within the last 24 months with commercial interests whose products or services are related to the subject matter of the presentation. Any real or apparent conflicts of interest are resolved prior to the presentation. All confirmed faculty disclosure is made available to participants prior to the activity. Faculty are also expected to disclose this information to the audience both verbally and in print (slide presentation) at the beginning of a presentation. Where applicable, faculty members must also inform learners if any unlabeled uses of products regulated by the U.S. Food and Drug Administration will be discussed.